Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043508 · ClinicalTrials.gov registry record
Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
A clinical trial of Genetic Mutation and MEN1, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT03043508 is a study of Genetic Mutation and MEN1 that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03043508, a study of Genetic Mutation and MEN1, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: The primary objective of this study is to evaluate the effect of estrogen on the development of the PNET in MEN1 patients. The secondary objective is to evaluate the overall survival and disease specific survival in patients who have confirmed MEN1 with or without PNET and a pancreatic neuroendocrine tumor in relation to their hormone status. The secondary objective is to evaluate clinicopathologic features in relation to hormone status.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- OTHER Chart Review
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-04-10 |
| Est. Completion | 2026-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03043508
The ClinicalTrials.gov registry entry for NCT03043508 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genetic Mutation appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.
NCT03043508 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03043508 about?
NCT03043508 is a clinical study titled "Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)". OBJECTIVES: The primary objective of this study is to evaluate the effect of estrogen on the development of the PNET in MEN1 patients. The secondary objective is to evaluate the overall survival and disease specific survival in patients who have confirmed MEN1 with or without PNET and a pancreatic...
What is the current status of trial NCT03043508?
This trial is currently active not recruiting. The enrollment target is 45 participants. The study started on 2015-04-10. Estimated completion is 2026-04-01.
What conditions does trial NCT03043508 study?
This clinical trial studies the following conditions: Genetic Mutation, MEN1.
What interventions are being tested in trial NCT03043508?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Chart Review (OTHER).
Who is sponsoring clinical trial NCT03043508?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03043508 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.